These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29411230)

  • 1. Hematologic Manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and Response to Tumor Necrosis Factor Inhibition in DADA2-Associated Bone Marrow Failure.
    Michniacki TF; Hannibal M; Ross CW; Frame DG; DuVall AS; Khoriaty R; Vander Lugt MT; Walkovich KJ
    J Clin Immunol; 2018 Feb; 38(2):166-173. PubMed ID: 29411230
    [No Abstract]   [Full Text] [Related]  

  • 2. Telomerase enzyme activity in Egyptian children with bone marrow failure and response to immunosuppressive therapy.
    El Beshlawy A; Said F; El Ansary M; Hamdy M; Abdel-Azim K; Abdel-Razek AA; Abulata N; Abdel-Salam A
    Blood Cells Mol Dis; 2017 Mar; 63():58-61. PubMed ID: 28160733
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic problems in acquired bone marrow failure syndromes.
    Nakao S
    Int J Hematol; 2016 Aug; 104(2):151-2. PubMed ID: 27380193
    [No Abstract]   [Full Text] [Related]  

  • 4. Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.
    Dell'Orso G; Grossi A; Penco F; Caorsi R; Palmisani E; Terranova P; Schena F; Lupia M; Ricci E; Montalto S; Pierri F; Ceccherini I; Fioredda F; Dufour C; Gattorno M; Miano M
    Front Immunol; 2021; 12():754029. PubMed ID: 34721429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2.
    Carmona-Rivera C; Khaznadar SS; Shwin KW; Irizarry-Caro JA; O'Neil LJ; Liu Y; Jacobson KA; Ombrello AK; Stone DL; Tsai WL; Kastner DL; Aksentijevich I; Kaplan MJ; Grayson PC
    Blood; 2019 Jul; 134(4):395-406. PubMed ID: 31015188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients.
    Hashem H; Bucciol G; Ozen S; Unal S; Bozkaya IO; Akarsu N; Taskinen M; Koskenvuo M; Saarela J; Dimitrova D; Hickstein DD; Hsu AP; Holland SM; Krance R; Sasa G; Kumar AR; Müller I; de Sousa MA; Delafontaine S; Moens L; Babor F; Barzaghi F; Cicalese MP; Bredius R; van Montfrans J; Baretta V; Cesaro S; Stepensky P; Benedicte N; Moshous D; Le Guenno G; Boutboul D; Dalal J; Brooks JP; Dokmeci E; Dara J; Lucas CL; Hambleton S; Wilson K; Jolles S; Koc Y; Güngör T; Schnider C; Candotti F; Steinmann S; Schulz A; Chambers C; Hershfield M; Ombrello A; Kanakry JA; Meyts I
    J Clin Immunol; 2021 Oct; 41(7):1633-1647. PubMed ID: 34324127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
    Lee PY; Kellner ES; Huang Y; Furutani E; Huang Z; Bainter W; Alosaimi MF; Stafstrom K; Platt CD; Stauber T; Raz S; Tirosh I; Weiss A; Jordan MB; Krupski C; Eleftheriou D; Brogan P; Sobh A; Baz Z; Lefranc G; Irani C; Kilic SS; El-Owaidy R; Lokeshwar MR; Pimpale P; Khubchandani R; Chambers EP; Chou J; Geha RS; Nigrovic PA; Zhou Q
    J Allergy Clin Immunol; 2020 Jun; 145(6):1664-1672.e10. PubMed ID: 31945408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A misleading case of deficiency of adenosine deaminase 2 (DADA2): the magnifying glass of the scientific knowledge drives the tailored medicine in real life.
    Maccora I; Frongia I; Azzari C; Ricci S; Cimaz R; Simonini G
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):146. PubMed ID: 30148442
    [No Abstract]   [Full Text] [Related]  

  • 9. Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2).
    Brooks JP; Rice AJ; Ji W; Lanahan SM; Konstantino M; Dara J; Hershfield MS; Cruickshank A; Dokmeci E; Lakhani S; Lucas CL
    J Clin Immunol; 2021 Apr; 41(3):680-683. PubMed ID: 33394316
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: I. Pathogenesis and pathophysiology of bone-marrow failure; 1. Aplastic anemia].
    Nakao S
    Nihon Naika Gakkai Zasshi; 2012 Jul; 101(7):1882-90. PubMed ID: 22896990
    [No Abstract]   [Full Text] [Related]  

  • 11. An altered gut microbiota may trigger autoimmune-mediated acquired bone marrow failure syndromes.
    Espinoza JL; Elbadry MI; Nakao S
    Clin Immunol; 2016 Oct; 171():62-64. PubMed ID: 27506961
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapamycin is highly effective in murine models of immune-mediated bone marrow failure.
    Feng X; Lin Z; Sun W; Hollinger MK; Desierto MJ; Keyvanfar K; Malide D; Muranski P; Chen J; Young NS
    Haematologica; 2017 Oct; 102(10):1691-1703. PubMed ID: 28729300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel ADA2 mutation presenting with neutropenia, lymphopenia and bone marrow failure in patients with deficiency in adenosine deaminase 2 (DADA2).
    Ghurye RR; Sundaram K; Smith F; Clark B; Simpson MA; Fairbanks L; Adhya Z; Mufti GJ; Marsh JCW; Ibrahim MAA
    Br J Haematol; 2019 Aug; 186(3):e60-e64. PubMed ID: 30924144
    [No Abstract]   [Full Text] [Related]  

  • 14. Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2.
    Hashem H; Egler R; Dalal J
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e293-e296. PubMed ID: 28230570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
    Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
    J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency.
    Kendall JL; Springer JM
    Curr Rheumatol Rep; 2020 Aug; 22(10):64. PubMed ID: 32845415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-α.
    Sahin S; Adrovic A; Barut K; Baran S; Tahir Turanli E; Canpolat N; Kizilkilic O; Ozkaya O; Kasapcopur O
    Paediatr Int Child Health; 2020 Feb; 40(1):65-68. PubMed ID: 30642227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary immunodeficiency and inherited bone marrow failure syndrome in adults].
    Takada H
    Rinsho Ketsueki; 2018; 59(10):2204-2211. PubMed ID: 30305527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2).
    Clarke K; Campbell C; Omoyinmi E; Hong Y; Al Obaidi M; Sebire N; Brogan PA
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):39. PubMed ID: 31291964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanercept treatment in Fanconi anaemia; combined US and Italian experience.
    Mehta PA; Svahn J; Davies SM; Pang Q; Harris R; Ghezzi P; Lanza T; Ferretti E; Barabino P; Mueller R; Dufour C
    Br J Haematol; 2012 Sep; 158(6):809-11. PubMed ID: 22834913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.